Prevalence of Helicobacter pylori in Formaldehyde Fixed Paraffin Embedded Gastric Tissues of Gastric Cancer Patients by Scorpion Real-Time PCR Assay

Cited By:

Creative Commons License
Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Prevalence of Helicobacter pylori in Formaldehyde Fixed Paraffin Embedded Gastric Tissues of Gastric Cancer Patients by Scorpion Real-Time PCR Assay


Amir Farzam 1 , 2
,
Reza Najafipour 1 , 3
,
Pouran Johari 1
and
Taghi Naserpour Farivar 1 , 4 , *

Authors Information

1 Cell and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, IR Iran
2 Department of Pathology, School of Medicine, Qazvin University of Medical Sciences, Qazvin, IR Iran
3 Department of Genetics, School of Medicine, Qazvin University of Medical Sciences, Qazvin, IR Iran
4 Department of Microbiology, School of Medicine, Qazvin University of Medical Sciences, Qazvin, IR Iran
Article information
  • Biotechnology and Health Sciences: November 01, 2014, 1 (3); e25836
  • Published Online: November 28, 2014
  • Article Type: Research Article
  • Received: August 4, 2014
  • Accepted: August 4, 2014
  • DOI: 10.17795/bhs-25836

To Cite: Farzam A, Najafipour R, Johari P, Naserpour Farivar T. Prevalence of Helicobacter pylori in Formaldehyde Fixed Paraffin Embedded Gastric Tissues of Gastric Cancer Patients by Scorpion Real-Time PCR Assay, Biotech Health Sci. 2014 ;1(3):e25836. doi: 10.17795/bhs-25836.

Abstract
Copyright © 2014, Qazvin University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
References
  • 1. Ferlay J, Bray F, Pisani P. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. 2001;
  • 2. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006; 12(3): 354-62[PubMed]
  • 3. Tiwari SK, Manoj G, Kumar GV, Sivaram G, Hassan SI, Prabhakar B, et al. Prognostic significance of genotyping Helicobacter pylori infection in patients in younger age groups with gastric cancer. Postgrad Med J. 2008; 84(990): 193-7[DOI][PubMed]
  • 4. Ries LAG, Kosary CL, Hankey BF. International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans. 1994; : 177–240
  • 5. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest. 2007; 117(1): 60-9[DOI][PubMed]
  • 6. Correa P, Piazuelo MB. Natural history of Helicobacter pylori infection. Dig Liver Dis. 2008; 40(7): 490-6[DOI][PubMed]
  • 7. McNamara D, El-Omar E. Helicobacter pylori infection and the pathogenesis of gastric cancer: a paradigm for host-bacterial interactions. Dig Liver Dis. 2008; 40(7): 504-9[DOI][PubMed]
  • 8. Fock KM, Dhamodaran S, Teo EK. Is H. pylori genotypes significant in Asian patients with gastric cancer and GERD? Gut. 55
  • 9. Erzin Y, Koksal V, Altun S, Dobrucali A, Aslan M, Erdamar S, et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsia. Helicobacter. 2006; 11(6): 574-80[DOI][PubMed]
  • 10. Chomvarin C, Namwat W, Chaicumpar K, Mairiang P, Sangchan A, Sripa B, et al. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and babA2 genotypes in Thai dyspeptic patients. Int J Infect Dis. 2008; 12(1): 30-6[DOI][PubMed]
  • 11. Ghasemi A, Shirazi MH, Ranjbar R, Khorramizadeh MR, Daryani NE, Hosseini M. The prevalence of cagA and cagE genes in Helicobacter pylori strains isolated from different patient groups by polymerase chain reaction. Pak J Biol Sci. 2008; 11(22): 2579-83[PubMed]
  • 12. Babus V, Strnad M, Presecki V, Katicic M, Kalinic S, Balija M. Helicobacter pylori and gastric cancer in Croatia. Cancer Lett. 1998; 125(1-2): 9-15[PubMed]
  • 13. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001; 49(3): 347-53[PubMed]
  • 14. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001; 345(11): 784-9[DOI][PubMed]
  • 15. Martinez T, Hernandez-Suarez G, Bravo MM, Trujillo E, Quiroga A, Albis R, et al. [Association of interleukin-1 genetic polymorphism and CagA positive Helicobacter pylori with gastric cancer in Colombia]. Rev Med Chil. 2011; 139(10): 1313-21[PubMed]
  • 16. Khanna AK, Seth P, Nath G, Dixit VK, Kumar M. Correlation of Helicobacter pylori and gastric carcinoma. J Postgrad Med. 2002; 48(1): 27-8[PubMed]
  • 17. Rudi J, Muller M, von Herbay A, Zuna I, Raedsch R, Stremmel W, et al. Lack of association of Helicobacter pylori seroprevalence and gastric cancer in a population with low gastric cancer incidence. Scand J Gastroenterol. 1995; 30(10): 958-63[PubMed]
  • 18. Burucoa C, Garnier M, Silvain C, Fauchere JL. Quadruplex real-time PCR assay using allele-specific scorpion primers for detection of mutations conferring clarithromycin resistance to Helicobacter pylori. J Clin Microbiol. 2008; 46(7): 2320-6[DOI][PubMed]
  • 19. Farivar TN, Pahlevan A, Johari P, Safdarian F, Mehr MA, Najafipour R, et al. Assessment of helicobacter pylori prevalence by scorpion real-time PCR in chronic tonsillitis patients. J Glob Infect Dis. 2012; 4(1): 38-42[DOI][PubMed]